Evidence map›Paper›PMID 26655298›Full record

ArticleThe Journal of infectious diseases2016

Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis.

Christina M Marra, Lauren C Tantalo, Sharon K Sahi, Shelia B Dunaway, Sheila A Lukehart

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Advancements in Syphilis Vaccine Development.Sexually transmitted diseases · 2026
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Development and utilization ofbioRxiv : the preprint server for biology · 2024
    Article
  12. Immunodominant extracellular loops ofbioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Previous Syphilis Alters the Course of Subsequent Episodes of Syphilis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christina M MarraDepartment of Neurology Department Medicine (Infectious Diseases).
Lauren C TantaloDepartment of Neurology.
Sharon K SahiDepartment of Neurology.
Shelia B DunawayDepartment Medicine (Infectious Diseases).
Sheila A LukehartDepartment Medicine (Infectious Diseases) Department Global Health, Harborview Medical Center, University of Washington, Seattle.
Harborview Medical Center · US

Funding

PERSISTENCE OF CNS T PALLIDUM IN HIV INFECTIONR01NS034235 · NINDS · UNIVERSITY OF WASHINGTON · PI MARRA, CHRISTINA M · 1996 to 2018
$7.0M
NINDS NIH HHS NS34235NINDS NIH HHS R01 NS034235
6 · The paper itself

Abstract

backgroundHuman immunodeficiency virus (HIV)-infected individuals may have poorer serological responses to syphilis treatment and may be more likely to experience neurosyphilis. Treponema pallidum is cleared from sites of infection by opsonization, ingestion, and killing by macrophages.

methodsSerum samples from 235 individuals with syphilis were tested for T. pallidum-specific opsonic activity. Blood T. pallidum concentrations were determined by real-time polymerase chain reaction amplification of the tp0574 gene, and T. pallidum was detected in cerebrospinal fluid (CSF) by reverse-transcriptase polymerase chain reaction of 16S ribosomal RNA.

resultsOpsonic activity was higher with higher serum rapid plasma reagin titers (P < .001), and in those treated for uncomplicated syphilis before serum collection (P < .001). Opsonic activity was lower in HIV-infected than in HIV-uninfected individuals even after the above factors were taken into account (P = .006). In participants in whom blood T. pallidum was detectable, those with the highest opsonic activity had lower blood T. pallidum concentrations. In multivariable analyses, there was not a significant relationship between opsonic activity and detection of T. pallidum in CSF or CSF-VDRL reactivity.

conclusionsSerum T. pallidum-specific opsonic activity is significantly lower in HIV-infected individuals. Impaired T. pallidum-specific immune responses could contribute to differences in the course of disease or treatment response.

Indexed as

AdultAntibodies, BacterialCohort StudiesFemaleHIV InfectionsHumansMaleMiddle AgedOpsonin ProteinsSyphilisTreponema pallidumAntibodies, BacterialOpsonin Proteinsimmune responseneuroinvasionneurosyphilisopsonic antibodysyphilis

Identifiers

PMID26655298
PMCPMC4799670
OpenAlexW2325061133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.